Impact of admission glycemia and glycosylated hemoglobin A1c on long-term clinical outcomes of non-diabetic patients with acute coronary syndrome
- 28 February 2014
- journal article
- Published by Elsevier BV in Journal of Cardiology
- Vol. 63 (2), 106-111
- https://doi.org/10.1016/j.jjcc.2013.07.009
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Impact of Admission Blood Glucose on Outcomes of Nondiabetic Patients With Acute ST-Elevation Myocardial Infarction (from the German Acute Coronary Syndromes [ACOS] Registry)The American Journal of Cardiology, 2009
- Association of Elevated Fasting Glucose With Increased Short-term and 6-Month Mortality in ST-Segment Elevation and Non–ST-Segment Elevation Acute Coronary SyndromesJAMA Internal Medicine, 2009
- Stress hyperglycaemia is an independent predictor of left ventricular remodelling after first anterior myocardial infarction in non-diabetic patientsEuropean Heart Journal, 2006
- Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention eraAmerican Heart Journal, 2005
- Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial InfarctionCirculation, 2005
- Prognostic value of admission glucose in non-diabetic patients with myocardial infarctionAmerican Heart Journal, 2004
- Admission Blood Glucose Level as Risk Indicator of Death After Myocardial Infarction in Patients With and Without Diabetes MellitusArchives of Internal Medicine, 2004
- Prognostic value of admission plasma glucose and HbA1c in acute myocardial infarctionDiabetic Medicine, 2004
- Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overviewThe Lancet, 2000
- Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients.Diabetes Care, 1999